REBLOZYL® (luspatercept-aamt) logo
Now approved for earlier treatment of MDS-related anemia badge

INDICATIONS (1 of 3)

REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions.

It is not known if REBLOZYL is safe or effective in children under 18 years of age.

Now approved for earlier treatment of MDS-related anemia badge

This website is best viewed using the horizontal display on your tablet device.

This website is best viewed using the vertical display on your mobile device.

Hypothetical patient with anemia in myelodysplastic syndromes with ring sideroblasts (MDS-RS)
Hypothetical patient with anemia in myelodysplastic syndromes with ring sideroblasts (MDS-RS)

How can I track my treatment with REBLOZYL?

How can I track my treatment with REBLOZYL?

In order to make the most of treatment with REBLOZYL, it’s important to keep track of your journey right from the start.

Be sure to talk to your healthcare team about what you should write down and track between REBLOZYL injections. This may include:

  • Your goals for treatment with REBLOZYL
  • Upcoming appointments and injection schedule
  • New or changing symptoms
  • Blood work results, including hemoglobin (Hgb) levels
  • Transfusion history, including date last received and how many units
  • Any questions/concerns that come up between appointments

Keeping track of your REBLOZYL dose is an important part of playing an active role in your treatment.

Your REBLOZYL dose may change over time. Be sure to write down and keep track of:

Hypothetical patient with anemia in myelodysplastic syndromes with ring sideroblasts (MDS-RS)
Hypothetical patient with anemia in myelodysplastic syndromes with ring sideroblasts (MDS-RS)

It may also help to keep track of how you feel over time, including changes in:

  • How often or long you need to rest
  • Ability to do daily tasks and activities,
    such as driving
  • Feeling dizzy
  • Feeling out of breath
  • Feeling weak

Improvement in any of these areas may be a sign your anemia is getting better. Talk to your healthcare team about how your dose may change to support your treatment goals.

You may feel like there is a lot of information to keep track of while receiving REBLOZYL. There are resources available to help you track your treatment and other important information throughout your journey with REBLOZYL.

Stay connected to the
support you need

Your REBLOZYL Connection is an educational program designed to help you understand your treatment with REBLOZYL, and provide resources that allow you to take a more active role with your care.

Talking with your healthcare team

It’s likely you will have questions about REBLOZYL during your treatment journey. There is a lot of new information to learn and a lot of things to keep track of. It’s important to talk with your healthcare team—they are here to help you along your journey. You can download the Doctor Discussion Guide to help with those conversations.

Hypothetical healthcare team

Your healthcare team wants to hear the details about how you’re doing. In order to have productive conversations with them, it’s important to keep track of your treatment and any new or changing symptoms.

Together, you and your healthcare team can make informed decisions about your REBLOZYL treatment.